fig1
![The <i>TNNI3</i> p.R186Q mutation is responsible for hypertrophic cardiomyopathy via promoting FASN-stimulated abnormal fatty acid metabolism](https://image.oaes.cc/77c8bd4b-4af1-454c-bb0d-654b20239147/5337.fig.1.jpg)
Figure 1. Tnni3R186Q/R186Q mice exhibit cardiomyocyte hypertrophy. (A) The cTnI protein expression level in sections of the ventricles of Tnni3+/+ and Tnni3R186Q/R186Q littermates (n = 3 per group). (B) The survival curve of Tnni3+/+ (n = 91) and Tnni3R186Q/R186Q (n = 78) mice. *P < 0.05, Log-Rank (Mantek-Cox) tests. (C) Representative M-mode echocardiographic images of Tnni3+/+ and Tnni3R186Q/R186Q mice at 10 months old. (D) Gross histological view (longitudinal section) of Tnni3+/+ and Tnni3R186Q/R186Q mice ventricular myocardium stained with HE (pink) and Masson’s trichrome staining (red) to reveal myocardial structure (100×). Scale bar 2 mm.